Table 4.
Basal insulin concentrations from several donkey studies compared to horse guidelines.
| Ref | Technique | Analyzer (Manufacturer) |
BCS | Insulin (µIU/mL) |
||
|---|---|---|---|---|---|---|
| Donkeys | [25] | ND | ND | ND | 1.3 (0–6.6) | |
| [50,51] | ND | ND | ND | 4.9 ± 0.5 | ||
| [51] | ND | ND | <3.5/5 * | 7.3 | ||
| >3.5/5 * | 20.9 | |||||
| [5] | IRMA | KIP1251 (DIASource ImmunoAssays, Louvain-La-Neuve, Belgium) |
4–9 | 9.1 (7.4–14.7) | ||
| 4–6 | 9.9 ± 0.8 | |||||
| >7 | 10.3 ± 0.6 | |||||
| [33] | IFIA | AIA 360 (Tosoh) | ND | 0–15.1 | ||
| [43] | RIA | Coat-a-Count (Siemens) |
2–3.5 | 2.7 ± 4.6 | ||
| 4–6 | 6 ± 4.6 | |||||
| 6.5–9 | 22.3 ± 4.6 | |||||
| [26] | CLIA | ADVIA Centaur XPT (Siemens) |
ND | 0.7–14.4 | ||
| Horses | [47] | CLIA | Immulite 2000 xpi (Siemens) |
ND | Non-diagnostic | <30 |
| ID suspect | 30–75 | |||||
| ID | >75 | |||||
| RIA/CLIA | ND/Immulite 1000 (Siemens) |
ND | Non-diagnostic | <20 | ||
| ID suspect | 20–50 | |||||
| ID | >50 |
Data are expressed as median (range), mean ± standard deviation or minimum–maximum. BCS, body condition score; CLIA, chemiluminescent immunoassay; IFIA, immunofluorescent immunoassay; IRMA, immunoradiometric assay; RIA, radioimmunoassay. * BCS is expressed out of 5. ND, not described.